Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study

The BMJ

Volumn 368, Issue , 2020, Pages

  Chen, Tao ^a   Wu, DI ^a   Chen, Huilong ^a   Yan, Weiming ^a   Yang, Danlei ^a   Chen, Guang ^a   Ma, Ke ^a   Xu, Dong ^a   Yu, Haijing ^a   Wang, Hongwu ^a   Wang, Tao ^a   Guo, Wei ^a   Chen, Jia ^a   Ding, Chen ^a   Zhang, Xiaoping ^a   Huang, Jiaquan ^a   Han, Meifang ^a   Li, Shusheng ^b   Luo, Xiaoping ^a   Zhao, Jianping ^a   Ning, Qin ^a   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; D DIMER; LACTATE DEHYDROGENASE; TROPONIN I; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CHEST TIGHTNESS; CHINA; CHRONIC DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTINUOUS RENAL REPLACEMENT THERAPY; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; CREATININE BLOOD LEVEL; DEATH; DISEASE COURSE; DISEASE DURATION; DYSPNEA; ELECTRONIC MEDICAL RECORD; HEART FAILURE; HEART INJURY; HUMAN; HYPERKALEMIA; HYPERTENSION; INFECTION PREVENTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; LYMPHOCYTOPENIA; OXYGEN THERAPY; PALLIATIVE THERAPY; PANDEMIC; PATIENT CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPSIS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEX RATIO; ADULT; AGED; BETACORONAVIRUS; BREATHING DISORDER; COMPLICATION; CONSCIOUSNESS DISORDER; EPIDEMIOLOGY; FEMALE; GENETICS; INFLAMMATION; ISOLATION AND PURIFICATION; LABORATORY TECHNIQUE; MALE; MIDDLE AGED; MORTALITY; RISK FACTOR; SEX FACTOR; TIME FACTOR; TREATMENT OUTCOME; VIRUS PNEUMONIA;

ADULT; AGE FACTORS; AGED; BETACORONAVIRUS; BIOMARKERS; CARDIOVASCULAR DISEASES; CHINA; CLINICAL LABORATORY TECHNIQUES; COMORBIDITY; CONSCIOUSNESS DISORDERS; CORONAVIRUS INFECTIONS; DYSPNEA; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RESPIRATION DISORDERS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85082561225     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.m1091     Document Type: Article

References (22)

1. Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76. 10.1056/NEJMoa030747 12690091
2. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814-20. 10.1056/NEJMoa1211721 23075143
3. Zhu N, Zhang D, Wang W, et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33. 10.1056/NEJMoa2001017 31978945
4. Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses 2020;12:E135. 10.3390/v12020135 31991541
5. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020. 10.1056/NEJMoa2001316 31995857
6. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514-23. 10.1016/S0140-6736(20)30154-9 31986261
7. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-3. 10.1038/s41586-020-2012-7 32015507
8. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. 10.1016/S0140-6736(20)30183-5 31986264
9. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. 10.1001/jama.2020.1585 32031570
10. New coronavirus pneumonia prevention and control program (6th ed) (in Chinese). 2020. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.
11. World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infectionwhen-novel-coronavirus-(ncov)-infection-is-suspected.
12. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179-84. 10.1159/000339789. 22890468
13. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006;27:330-7. 10.1093/eurheartj/ehi631 16293638
14. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020. 10.1001/jama.2020.2648 32091533
15. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 2003. https://www.who.int/csr/sars/country/table2004- 04-21/en/.
16. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2019. https://www.who.int/emergencies/mers-cov/en/.
17. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13. 10.1016/S0140-6736(20)30211-7 32007143
18. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41:145-51. 10.3760/cma.j.issn.0254-6450.2020.02.003. 32064853
19. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series [correction in: BMJ 2020;368:m792]. BMJ 2020;368:m606. 10.1136/bmj.m606 32075786
20. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;S2213-2600(20)30076-X. 10.1016/S2213-2600(20)30076-X. 32085846
21. Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS?Lancet Infect Dis 2020;S1473-3099(20)30129-8. 10.1016/S1473-3099(20)30129-8. 32145768
22. Liu CL, Lu YT, Peng MJ, et al. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest 2004;126:509-17. 10.1378/chest.126.2.509 15302738